IHS Chemical Week

Chemical Week Magazine :: Business & Finance :: United States/Americas

Chr. Hansen Buys Biotech Firm

12:11 PM MST | February 9, 2009

Chr. Hansen has acquired privately owned biotech firm Urex Biotech (Toronto), which focuses on human health and nutrition concerns. Terms were not disclosed. The deal expands Chr. Hansen’s portfolio of probiotics for dietary supplements, Chr. Hansen says. The companies partnered in 2004 to develop therapeutic products based on probiotic strains, targeting women’s health...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa